Cargando…

Gaps in guideline-recommended anticoagulation in patients with atrial fibrillation and elevated thromboembolic risk within an integrated healthcare delivery system

BACKGROUND: Atrial Fibrillation (AF) is the leading cause of stroke, which can be reduced by 70% with appropriate oral anticoagulation (OAC) therapy. Nationally, appropriate anticoagulation rates for patients with AF with elevated thromboembolic risk are as low as 50% even across the highest stroke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malik, Sushmita, Gustafson, Shanshan, Chang, Huai-En R., Tamrat, Yonas, Go, Alan S., Berry, Natalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664365/ https://www.ncbi.nlm.nih.gov/pubmed/37990153 http://dx.doi.org/10.1186/s12872-023-03607-y

Ejemplares similares

Variation in Anticoagulant Recommendations by the Guidelines and Decision Tools among Patients with Atrial Fibrillation
por: Shewale, Anand, et al.
Publicado: (2015)

Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation
por: Matos, Jason D., et al.
Publicado: (2018)

Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction
por: Jortveit, Jarle, et al.
Publicado: (2022)

Anticoagulation in Cancer Patients With Atrial Fibrillation or Atrial Flutter: Are There Gaps in Care?
por: Russo, Andrea M.
Publicado: (2020)

Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response
por: Rago, Anna, et al.
Publicado: (2023)

Length of Anticoagulation in Provoked Venous Thromboembolism: A Multicenter Study of How Real‐World Practice Mirrors Guideline Recommendations
por: Joyce, Elizabeth, et al.
Publicado: (2022)

Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy
por: Søgaard, Mette, et al.
Publicado: (2022)

Initiation of Guideline-Matched Oral Anticoagulant in Atrial Fibrillation-Related Stroke
por: Eun, Mi-Yeon, et al.
Publicado: (2021)

Education and practice gaps on atrial fibrillation and anticoagulation: a survey of cardiovascular nurses
por: Ferguson, Caleb, et al.
Publicado: (2016)

Evidence‐Practice Gaps in Postdischarge Initiation With Oral Anticoagulants in Patients With Atrial Fibrillation
por: Schaffer, Andrea L., et al.
Publicado: (2019)

Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy
por: Magnocavallo, Michele, et al.
Publicado: (2020)

Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy
por: An, Myeonghyun, et al.
Publicado: (2023)

Sepsis-driven atrial fibrillation and ischaemic stroke. Is there enough evidence to recommend anticoagulation?
por: Induruwa, Isuru, et al.
Publicado: (2022)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Practice Gap in Atrial Fibrillation Oral Anticoagulation Prescribing at Emergency Department Home Discharge
por: Kea, Bory, et al.
Publicado: (2020)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
por: Rohla, Miklos, et al.
Publicado: (2019)

Stability of High‐Quality Warfarin Anticoagulation in a Community‐Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
por: Dallalzadeh, Liane O., et al.
Publicado: (2016)

Elevated plasma Ninjurin-1 levels in atrial fibrillation is associated with atrial remodeling and thromboembolic risk
por: Fang, Chen, et al.
Publicado: (2022)

Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular risk
por: Stühlinger, Markus C., et al.
Publicado: (2019)

Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
por: Königsbrügge, Oliver, et al.
Publicado: (2016)

Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation
por: Hong, Keun-Sik
Publicado: (2019)

Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and High Thromboembolic Risk. A Systematic Review
por: Acanfora, Domenico, et al.
Publicado: (2019)

Healthcare Resource Utilization for Oral Anticoagulant Reversal Therapies in Non-Valvular Atrial Fibrillation/Venous Thromboembolism Patients
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia
por: Yimer, Nuredin Shiferaw, et al.
Publicado: (2021)

Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults – a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing
por: Sommerauer, Christina, et al.
Publicado: (2017)

Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
por: Gustafson, Whitney L., et al.
Publicado: (2019)

Results from the Registry of Atrial Fibrillation (AFABE): Gap between Undiagnosed and Registered Atrial Fibrillation in Adults—Ineffectiveness of Oral Anticoagulation Treatment with VKA
por: Panisello-Tafalla, Anna, et al.
Publicado: (2015)

Evidence gaps pertaining to high-risk medications: Commentary on anticoagulation in new-onset postoperative atrial fibrillation
por: Akowuah, Enoch, et al.
Publicado: (2022)

Effect of non‐recommended doses versus recommended doses of direct oral anticoagulants in atrial fibrillation patients: A meta‐analysis
por: Liu, Xuyang, et al.
Publicado: (2021)

Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline
por: Gray, Matthew P., et al.
Publicado: (2018)

Efficacy and Safety of Direct Oral Anticoagulants Compared to Warfarin in Prevention of Thromboembolic Events Among Elderly Patients with Atrial Fibrillation
por: Kailas, Shilpa D, et al.
Publicado: (2016)

Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review
por: Ballestri, Stefano, et al.
Publicado: (2022)

Atrial Fibrillation and Cryptogenic Thromboembolic Events
por: Henz, Benhur Davi, et al.
Publicado: (2018)

Correction to: Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults – a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing
por: Sommerauer, Christina, et al.
Publicado: (2018)

CKD-MBD in Brazil: the gap between reality and the recommended guidelines
por: Custódio, Melani Ribeiro
Publicado: (2018)

Gaps between Real-world Practice and Guidelines in Managing Patients with Atrial Fibrillation in Korea
por: Park, Hyoung-Seob, et al.
Publicado: (2017)

ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry
por: Wang, Yufeng, et al.
Publicado: (2023)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_49vqab41ssm9rs7pugdueg8tpu